Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-12

Clinical Trial Update: Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects [Phase 3]

View source ↗

Summary

This update reports the Phase 3 results of olopatadine hydrochloride ophthalmic solution tested in Chinese subjects for allergic conjunctivitis. The trial resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION (olopatadine hydrochloride ophthalmic solution)

Snippet

Sponsor: Alcon Research | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2016-10-12